| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |